Scisparc Announces Renewal of Approval by Israeli Medical Cannabis Agency for Its Clinical Trial in Children With Autism Spectrum Disorder
Scisparc 宣佈以色列醫療大麻機構續期批准其針對自閉症譜系障礙兒童的臨牀試驗。
Scisparc Announces Renewal of Approval by Israeli Medical Cannabis Agency for Its Clinical Trial in Children With Autism Spectrum Disorder
Scisparc 宣佈以色列醫療大麻機構續期批准其針對自閉症譜系障礙兒童的臨牀試驗。
使用瀏覽器的分享功能,分享給你的好友吧